-
公开(公告)号:US20130281691A1
公开(公告)日:2013-10-24
申请号:US13743166
申请日:2013-01-16
申请人: Metabolex, Inc.
发明人: Xin Chen , Peng Cheng , L. Edward Clemens , Jeffrey D. Johnson , Jingyuan Ma , Alison Murphy , Imad Nashashibi , Christopher J. Rabbat , Jiangao Song , Maria E. Wilson , Yan Zhu , Zuchun Zhao
IPC分类号: C07D417/14 , C07D413/14 , C07D417/04
CPC分类号: A61K31/506 , A61K31/454 , C07D277/42 , C07D401/04 , C07D401/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/14
摘要: Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.
-
公开(公告)号:US20130131351A1
公开(公告)日:2013-05-23
申请号:US13646409
申请日:2012-10-05
申请人: Metabolex, Inc.
发明人: Dong Fang Shi , Jiangao Song , Christopher J. Rabbat , Jingyuan Ma , Aaron Novack , Imad Fayek Nashashibi , Xin Chen , Phuongly Pham
IPC分类号: C07D407/12 , C07D307/80 , C07D405/10 , C07D307/79 , C07D307/83
CPC分类号: C07D405/04 , C07D213/64 , C07D231/56 , C07D235/12 , C07D307/79 , C07D307/80 , C07D307/83 , C07D307/94 , C07D311/58 , C07D319/08 , C07D333/54 , C07D333/60 , C07D405/10 , C07D407/04 , C07D407/12
摘要: GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.
摘要翻译: 提供GPR120激动剂。 这些化合物可用于治疗代谢疾病,包括II型糖尿病和与血糖控制不良相关的疾病。
-
公开(公告)号:US08476308B2
公开(公告)日:2013-07-02
申请号:US13645287
申请日:2012-10-04
申请人: Metabolex, Inc.
发明人: Dong Fang Shi , Jiangao Song , Jingyuan Ma , Aaron Novack , Phuongly Pham , Imad Fayek Nashashibi , Christopher J. Rabbat , Xin Chen
IPC分类号: A61K31/405 , C07D209/08
CPC分类号: C07D209/08 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/381 , A61K31/41 , A61K31/416 , A61K31/44 , C07B59/002 , C07D211/76 , C07D231/56 , C07D307/79 , C07D307/83 , C07D307/94 , C07D311/58 , C07D319/08 , C07D333/54 , C07D405/10
摘要: GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.
摘要翻译: 提供GPR120激动剂。 这些化合物可用于治疗代谢疾病,包括II型糖尿病和与血糖控制不良相关的疾病。
-
公开(公告)号:US08598374B2
公开(公告)日:2013-12-03
申请号:US13646409
申请日:2012-10-05
申请人: Metabolex, Inc
发明人: Dong Fang Shi , Jiangao Song , Christopher J. Rabbat , Jingyuan Ma , Aaron Novack , Imad Fayek Nashashibi , Xin Chen , Phuongly Pham
IPC分类号: C07D307/87
CPC分类号: C07D405/04 , C07D213/64 , C07D231/56 , C07D235/12 , C07D307/79 , C07D307/80 , C07D307/83 , C07D307/94 , C07D311/58 , C07D319/08 , C07D333/54 , C07D333/60 , C07D405/10 , C07D407/04 , C07D407/12
摘要: GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.
-
公开(公告)号:US20140121246A1
公开(公告)日:2014-05-01
申请号:US14054385
申请日:2013-10-15
申请人: Metabolex, Inc.
发明人: Dong Fang Shi , Jiangao Song , Christopher J. Rabbat , Jingyuan Ma , Aaron Novack , Imad Nashashibi , Xin Chen
IPC分类号: C07D405/04 , C07D311/58 , C07D213/64 , C07D307/83 , C07D333/60 , C07D307/94 , C07D307/80 , C07D319/08
CPC分类号: C07D405/04 , C07D213/64 , C07D231/56 , C07D235/12 , C07D307/79 , C07D307/80 , C07D307/83 , C07D307/94 , C07D311/58 , C07D319/08 , C07D333/54 , C07D333/60 , C07D405/10 , C07D407/04 , C07D407/12
摘要: GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.
摘要翻译: 提供GPR120激动剂。 这些化合物可用于治疗代谢疾病,包括II型糖尿病和与血糖控制不良相关的疾病。
-
公开(公告)号:US20130109734A1
公开(公告)日:2013-05-02
申请号:US13645287
申请日:2012-10-04
申请人: Metabolex, Inc.
发明人: Dong Fang Shi , Jiangao Song , Jingyuan Ma , Aaron Novack , Phuongly Pham , Imad Fayek Nashashibi , Christopher J. Rabbat , Xin Chen
IPC分类号: C07D209/08
CPC分类号: C07D209/08 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/381 , A61K31/41 , A61K31/416 , A61K31/44 , C07B59/002 , C07D211/76 , C07D231/56 , C07D307/79 , C07D307/83 , C07D307/94 , C07D311/58 , C07D319/08 , C07D333/54 , C07D405/10
摘要: GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.
-
-
-
-
-